The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. (hvtn.org)
Dr. Mark Manak heads up the research activities of MHRP's Department of Laboratory Diagnostics and Monitoring, focusing on evaluation of diagnostic assays and their applications in screening for HIV and related infectious diseases and monitoring efficacy of intervention programs. (hivresearch.org)
In fact, the trial was terminated early based on the recommendation of an independent data and safety monitoring board because an interim analysis demonstrated efficacy of the intervention with 49 percent of the enrollment target. (sciencedaily.com)